New drug targets hard-to-treat cancers in early trial
NCT ID NCT04446260
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This early-phase study tested an experimental drug called SHR-A1811 in 396 adults with advanced solid tumors that have a specific marker (HER2). The main goals were to check safety and how the drug moves through the body. Researchers also looked for signs that the drug might shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alfred Hospital
Melbourne, 3004, Australia
-
Asan Medical Center
Seoul, 5505, South Korea
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
-
Chang Gung Memorial Hospital, Linkou
Taoyuan District, 333, Taiwan
-
China Medical University Hospital
Taichung, 40447, Taiwan
-
Fudan University Shanghai cancer center
Shanghai, Shanghai Municipality, 200032, China
-
Fudan Unversity Zhongshan Hospital
Shanghai, Shanghai Municipality, 200032, China
-
Fujian Cancer Hospital
Fujian, Fuzhou, 350000, China
-
Greenville Hospital System
Greenville, South Carolina, 29605, United States
-
Henan cancer Hospital
Zhengzhou, Henan, 450003, China
-
Hubei cancer hospital
Wuhan, Hubei, 430079, China
-
Hunan cancer hospital
Changsha, Hunan, 410031, China
-
Jiangsu Province Hospital
Nanjing, Jiangsu, 210000, China
-
Macquarie University Hospital
Macquarie, New South Wales, 2109, Australia
-
Mary Crowley Cancer Research
Dallas, Texas, 75230, United States
-
Montefiore-Einstein Center for Cancer Care
The Bronx, New York, 10461, United States
-
Nanfang Hospital
Guangzhou, Guangdong, 510120, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
-
National Cheng Kung University Hospital
Tainan, 70457, Taiwan
-
Nucleus Network
Melbourne, Victoria, 3004, Australia
-
Peninsula and South Eastern Haematology & Oncology Group
Frankston, Victoria, 3199, Australia
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
-
Seoul National University Hospital
Seoul, 3080, South Korea
-
Shanghai Jiao Tong University School of Medicine Renji Hospital
Shanghai, Shanghai Municipality, 200032, China
-
Shanxi Cancer Hospital
Taiyuan, Shanxi, 030000, China
-
Shengjing Hospital of China medical university
Shengyang, Liaoning, 110022, China
-
Sichuan Cancer Hospital
Chengdu, Sichuan, 610042, China
-
Southern Oncology Clinical Research Unit
Bedford Park, South Australia, 5042, Australia
-
Sun Yat-Sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
-
The first affiliated hospital of bengbu medical college
Bengbu, Anhui, 233000, China
-
The second affiliated hospital Zhejiang university school of medicine
Hangzhou, Zhejiang, 310014, China
-
Tianjin medical university cancer institute&hoospital
Tianjin, Tianjin Municipality, 300181, China
-
Xiangya hospital central south university
Changsha, Hunan, 410008, China
-
Zhejiang provincial people's hospital
Hangzhou, Zhejiang, 310014, China
-
Zhongnan hospital of Wuhan university
Wuhan, Hubei, 430062, China
Conditions
Explore the condition pages connected to this study.